Peptide therapy is generally not appropriate for patients who are pregnant, breastfeeding, have active hormone-sensitive cancers, or uncontrolled autoimmune conditions
PLOS ONE 9 , e100778 (2014)
It is highly unlikely that any patch on the market today will deliver the same life-changing effects of GLP-1 medications
This includes TB-500 10mg, BPC-157 10mg, all ipamorelin formats (5mg and 10mg), all CJC-1295 formats (With and Without DAC), all tesamorelin formats (5mg and 10mg), all sermorelin formats (2mg and 5mg), GHK-CU 50mg and 100mg, MT-1 10mg, MT-2 10mg, MOTS-C 10mg and 40mg, and AOD-9604 5mg and 10mg
Early Treatment Phase During the first few weeks, changes in eating patterns and fluid intake can lead to dizziness